- Date: July 24, 2018
Spanish biotechnology companies received €149 million last year, 17% more than in 2016. The sector’s economic impact was worth 0.7% of Spanish GDP (€7.3 billion), and helped create over 108,000 jobs. These are some of the conclusions reached in the latest Annual Report published by the Spanish Association of Biotech Companies (ASEBIO).
In a breakdown by type of financial operation, the report highlights €93.7 million spent on increased private equity investments, €41 million in share capital increases, and €10.8 million on related operations and participation loans. There were also significant levels of venture capital activity in 2017, with entities in the sector, such as Caixa Capital Risc, investing a total of €30 million.
The report also provides data from the 2016 Innovation in Companies Survey carried out by the Spanish National Statistics Institute, showing that €617 million were invested in R&D in the Spanish biotechnology sector, 6.6% more than in 2015. The main area of activity is human health (66.8%), followed by food (23.5%). Most companies in the sector are found in the autonomous community of Catalonia (19.3%), followed by Andalusia (13.5%) and Galicia (8.6%).
December 18, 2018
The EIT Health Summit, held on 4-5 December in Łódź (Poland), brought together over 400 experts in medical innovation from all over Europe.
November 29, 2018
”La Caixa” Banking Foundation (LCF) has launched the second edition of the open call for Health Research projects, which will remain open until 15 January.
November 27, 2018
Highly innovative start-ups and SMEs from Spain and Portugal are invited to apply for the EntrepreneurXXI Awards until 12 December.